Alpha-tocopherol_NN
inhibits_VBZ
agonist-induced_JJ
monocytic_JJ
cell_NN
adhesion_NN
to_TO
cultured_VBN
human_JJ
endothelial_JJ
cells_NNS
._.

Antioxidants_NNS
have_VBP
been_VBN
proposed_VBN
to_TO
be_VB
anti-atherosclerotic_JJ
agents_NNS
;_:
however_RB
,_,
the_DT
mechanisms_NNS
underlying_VBG
their_PRP$
beneficial_JJ
effects_NNS
are_VBP
poorly_RB
understood_VBN
._.

We_PRP
have_VBP
examined_VBN
the_DT
effect_NN
of_IN
alpha-tocopherol_NN
-LRB-_-LRB-
alpha-tcp_NN
-RRB-_-RRB-
on_IN
one_CD
cellular_JJ
event_NN
in_IN
atherosclerotic_JJ
plaque_NN
development_NN
,_,
monocyte_NN
adhesion_NN
to_TO
stimulated_VBN
endothelial_JJ
cells_NNS
-LRB-_-LRB-
ECs_NNS
-RRB-_-RRB-
._.

Human_JJ
umbilical_JJ
vein_NN
ECs_NNS
were_VBD
pretreated_VBN
with_IN
alpha-tcp_NN
before_IN
stimulation_NN
with_IN
known_JJ
agonists_NNS
of_IN
monocyte_NN
adhesion_NN
:_:
IL-1_NN
-LRB-_-LRB-
10_CD
ng\/ml_NN
-RRB-_-RRB-
,_,
LPS_NN
-LRB-_-LRB-
10_CD
ng\/ml_NN
-RRB-_-RRB-
,_,
thrombin_NN
-LRB-_-LRB-
30_CD
U\/ml_NN
-RRB-_-RRB-
,_,
or_CC
PMA_NN
-LRB-_-LRB-
10_CD
nM_NN
-RRB-_-RRB-
._.

Agonist-induced_JJ
monocytic_JJ
cell_NN
adhesion_NN
,_,
but_CC
not_RB
basal_JJ
adhesion_NN
,_,
was_VBD
inhibited_VBN
in_IN
a_DT
time_NN
-_:
and_CC
concentration-dependent_JJ
manner_NN
by_IN
alpha-tcp_NN
._.

The_DT
IC50_NN
of_IN
alpha-tcp_NN
on_IN
an_DT
IL-1-induced_JJ
response_NN
was_VBD
45_CD
microM_NN
._.

The_DT
inhibition_NN
correlated_VBD
with_IN
a_DT
decrease_NN
in_IN
steady_JJ
state_NN
levels_NNS
of_IN
E-selectin_NN
mRNA_NN
and_CC
cell_NN
surface_NN
expression_NN
of_IN
E-selectin_NN
which_WDT
is_VBZ
consistent_JJ
with_IN
the_DT
ability_NN
of_IN
a_DT
monoclonal_JJ
antibody_NN
to_TO
E-selectin_NN
to_TO
inhibit_VB
monocytic_JJ
cell_NN
adhesion_NN
in_IN
this_DT
system_NN
._.

Probucol_NN
-LRB-_-LRB-
50_CD
microM_NN
-RRB-_-RRB-
and_CC
N-acetylcysteine_NN
-LRB-_-LRB-
20_CD
mM_NN
-RRB-_-RRB-
also_RB
inhibited_VBD
agonist-induced_JJ
monocytic_JJ
cell_NN
adhesion_NN
;_:
whereas_IN
,_,
several_JJ
other_JJ
antioxidants_NNS
had_VBD
no_DT
significant_JJ
effect_NN
._.

Protein_NN
kinase_NN
C_NN
-LRB-_-LRB-
PKC_NN
-RRB-_-RRB-
does_VBZ
not_RB
appear_VB
to_TO
play_VB
a_DT
role_NN
in_IN
the_DT
alpha-tcp_NN
effect_NN
since_IN
no_DT
suppression_NN
of_IN
phosphorylation_NN
of_IN
PKC_NN
substrates_NNS
was_VBD
observed_VBN
._.

Activation_NN
of_IN
the_DT
transcription_NN
factor_NN
NF-kappa_NN
B_NN
is_VBZ
reported_VBN
to_TO
be_VB
necessary_JJ
but_CC
not_RB
sufficient_JJ
for_IN
E-selectin_NN
expression_NN
in_IN
EC_NN
._.

Electrophoretic_JJ
mobility_NN
shift_NN
assays_NNS
failed_VBD
to_TO
show_VB
an_DT
alpha-tcp-induced_JJ
decrease_NN
in_IN
activation_NN
of_IN
this_DT
transcription_NN
factor_NN
after_IN
cytokine_NN
stimulation_NN
._.

It_PRP
has_VBZ
been_VBN
hypothesized_VBN
that_IN
alpha-tcp_NN
acts_VBZ
as_IN
an_DT
anti-atherosclerotic_JJ
molecule_NN
by_IN
inhibiting_VBG
generation_NN
of_IN
oxidized_VBN
LDL_NN
--_:
a_DT
putative_JJ
triggering_VBG
molecule_NN
in_IN
the_DT
atherosclerotic_JJ
process_NN
._.

Our_PRP$
results_NNS
point_VBP
to_TO
a_DT
novel_JJ
alternative_JJ
mechanism_NN
of_IN
action_NN
of_IN
alpha-tcp_NN
._.

